Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (S

Novo Nordisk · Phase 3 · Completed · Enrollment 573

NCT05514535

EudraCT 2021-004392-13

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Insuline glargine U100 (reduced) + semaglutiden/rn/rn/rn/r
Insuline glargine U100 (titrated)n/rn/rn/rn/r

Not shown

  • Insuline glargine U100 (reduced) + semaglutide: endpoint not reported
  • Insuline glargine U100 (titrated): endpoint not reported